Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab

The Lancet Rheumatology 2026

View at publisher
Authors: Athimalaipet V Ramanan, Nicolino Ruperto, Ivan Foeldvari, Gabriel Vega-Cornejo, Stuart Keller, Rona Wang, Joana Araújo, Priyanka Sen, Ketan Marulkar, James Tseng, Celine Pitou, Pierre Quartier
DOI: 10.1016/s2665-9913(25)00346-7
Cited by: 3
References: 29

Fields of Study & Subjects

Spondyloarthritis Studies and Treatments Autoimmune and Inflammatory Disorders Research Psoriasis: Treatment and Pathogenesis

Publication details

Journal / source
The Lancet Rheumatology
Publisher
Elsevier BV
Volume
8
Issue
5
Pages
e377–e388
Publication date
2 March 2026
Language
EN